Showing results (1191-1200 of 1,335) with videos related to
Sort By:
Pageof 134
Journal of Diabetes|November 5, 2020
Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: The randomized, partially double-blinded, controlled ACUDIN trialGesa Meyer-Hamme, Thomas Friedemann, Johannes Greten, et al.Journal of Diabetes|December 22, 2020
Determinants of mental health outcomes among people with and without diabetes during the COVID-19 outbreak in the Arab Gulf RegionMohammed E Al-Sofiani, Sarah Albunyan, Abdullah M Alguwaihes, et al.Journal of Diabetes|November 2, 2021
Relationships between type 2 diabetes, cell dysfunction, and redox signaling: A meta-analysis of single-cell gene expression of human pancreatic α- and β-cellsEmily Sara Marques, Emily Formato, Wenle Liang, et al.Journal of Diabetes|May 5, 2022
Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetesChen Xu, Li Li, Juan Shi, et al.Journal of Diabetes|February 6, 2016
Urinary α1 -microglobulin and albumin excretion in children and adolescents with type 1 diabetesAasem Saif, Neveen SolimanJournal of Diabetes|February 6, 2016
The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetesMaría Del Rosario Vallejo-Mora, Mónica Carreira-Soler, Francisca Linares-Parrado, et al.Journal of Diabetes|January 6, 2016
Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysisStephen M Twigg, Mirella M Daja, Beth A O'leary, et al.Journal of Diabetes|December 24, 2015
Dutch diabetes prevalence estimates (DUDE-1)Nanne Kleefstra, Gijs W D Landman, Kornelis J J Van Hateren, et al.Journal of Diabetes|December 11, 2014
A toxicology study to evaluate the embryotoxicity of metformin compared with the hypoglycemic drugs, the anticancer drug, the anti-epileptic drug, the antibiotic, and the cyclo-oxygenase (COX)-2 inhibitorLi Li, Xing Zhang, Lei Wang, et al.Journal of Diabetes|December 11, 2014
Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern populationErfan Ayubi, Davood Khalili, Ali Delpisheh, et al.Pageof 134